{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer cells", "carbon nanotubes", "codelivery system", "diosgenin and ferulic acid", "kinetic release", "long noncoding RNAs/microRNAs/TGF-\u03b2 and E-cadherin protein"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38253026", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "20"}, "DateRevised": {"Year": "2024", "Month": "06", "Day": "11"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1021/acsabm.3c00700"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "22"}], "Journal": {"ISSN": "2576-6422", "JournalIssue": {"Volume": "7", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "19"}}, "Title": "ACS applied bio materials", "ISOAbbreviation": "ACS Appl Bio Mater"}, "ArticleTitle": "Functionalized Carbon Nanotubes for Delivery of Ferulic Acid and Diosgenin Anticancer Natural Agents.", "Pagination": {"StartPage": "791", "EndPage": "811", "MedlinePgn": "791-811"}, "Abstract": {"AbstractText": ["It was investigated whether loading multi-wall carbon nanotubes (CNTs) with two natural anticancer agents: ferulic acid (FUA) and diosgenin (DGN), may enhance the anticancer effect of these drugs. The CNTs were functionalized with carboxylic acid (CNTCOOH) or amine (CNTNH<sub>2</sub>), loaded with the above pro-drugs, as well as both combined and coated with chitosan or chitosan-stearic acid. Following physicochemical characterization, the drug-loading properties and kinetics of the drug's release were investigated. Their effects on normal human skin fibroblasts and MCF-7 breast carcinoma cells, HepG2 hepatocellular carcinoma cells, and A549 non-small-cell lung cancer cells were evaluated in vitro. Their actions at the molecular level were evaluated by assessing the expression of lncRNAs (HULC, HOTAIR, CCAT-2, H19, and HOTTIP), microRNAs (mir-21, mir-92, mir-145, and mir-181a), and proteins (TGF-\u03b2 and <i>E</i>-cadherin) in HepG2 cells. The release of both pro-drugs depended on the glutathione concentration, coating, and functionalization. Release occurred in two stages: a no-burst/zero-order release followed by a sustained release best fitted to Korsmeyer-Peppas kinetics. The combined nanoformulation cancer inhibition effect on HepG2 cancer cells was more pronounced than for A549 and MCF7 cells. The combined nanoformulations had an additive impact followed by a synergistic effect, with antagonism demonstrated at high concentrations. The nanoformulation coated with chitosan and stearic acid was particularly successful in targeting HepG2 cells and inducing apoptosis. The CNT functionalized with carboxylic acid (CNTCOOH), loaded with both FUA and DGN, and coated with chitosan-stearic acid inhibited the expression of lncRNAs and modulated both microRNAs and proteins. Thus, nanoformulations composed of functionalized CNTs dual-loaded with FUA and DGN and coated with chitosan-stearic acid are a promising drug delivery system that enhances the activity of natural pro-drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth Street, Dokki, Giza 12622, Egypt."}], "LastName": "AbouAitah", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Supplementary General Sciences, Future University, End of 90th Street, Fifth Settlement, New Cairo 11835, Egypt."}], "LastName": "Abdelaziz", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Pharmaceutical and Drug Industries Research Institute, National Research Centre (NRC), 33 El-Behouth Street, Dokki, Giza 12622, Egypt."}], "LastName": "Higazy", "ForeName": "Imane M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Swiderska-Sroda", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Analytical Chemistry Department, Faculty of Pharmacy, October 6 University, Giza 12585, Egypt."}], "LastName": "Hassan", "ForeName": "Abeer M E", "Initials": "AME"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo 11511, Egypt."}], "LastName": "Shaker", "ForeName": "Olfat G", "Initials": "OG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}, {"Identifier": [], "Affiliation": "Faculty of Materials Engineering, Warsaw University of Technology, Wo\u0142oska 41, 02-507 Warsaw, Poland."}], "LastName": "Sza\u0142aj", "ForeName": "Urszula", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "NANOMATPL Ltd., 14/38 Wyszogrodzka Street, Warsaw 03-337, Poland."}, {"Identifier": [], "Affiliation": "Faculty of Chemical and Process Engineering, Warsaw University of Technology, 1 Warynskiego Street, 00-645 Warsaw, Poland."}], "LastName": "Stobinski", "ForeName": "Leszek", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Chemical and Process Engineering, Warsaw University of Technology, 1 Warynskiego Street, 00-645 Warsaw, Poland."}], "LastName": "Malolepszy", "ForeName": "Artur", "Initials": "A"}, {"Identifier": ["0000-0001-8521-0688"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of High Pressure Physics, Polish Academy of Sciences, Sokolowska 29/37, 01-142 Warsaw, Poland."}], "LastName": "Lojkowski", "ForeName": "Witold", "Initials": "W"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Appl Bio Mater", "NlmUniqueID": "101729147", "ISSNLinking": "2576-6422"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Nanotubes, Carbon"}, {"RegistryNumber": "AVM951ZWST", "NameOfSubstance": "ferulic acid"}, {"RegistryNumber": "9012-76-4", "NameOfSubstance": "Chitosan"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Long Noncoding"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coumaric Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Prodrugs"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN145 microRNA, human"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanotubes, Carbon"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Chitosan"}, {"QualifierName": [], "DescriptorName": "Carcinoma, Non-Small-Cell Lung"}, {"QualifierName": [], "DescriptorName": "RNA, Long Noncoding"}, {"QualifierName": [], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Coumaric Acids"}, {"QualifierName": [], "DescriptorName": "Prodrugs"}, {"QualifierName": [], "DescriptorName": "MicroRNAs"}], "CoiStatement": "The authors\ndeclare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Amin H. H.; Meghani N. M.; Park C.; Nguyen V. H.; Tran T. T.; Tran P. H.; Lee B. J. Fattigation-platform nanoparticles using apo-transferrin stearic acid as a core for receptor-oriented cancer targeting. Colloids Surf., B 2017, 159, 571\u2013579. 10.1016/j.colsurfb.2017.08.014.", "ArticleIdList": ["10.1016/j.colsurfb.2017.08.014", "28854413"]}, {"Citation": "Lombardo D.; Kiselev M. A.; Caccamo M. T. Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine. J. Nanomater. 2019, 2019, 3702518.10.1155/2019/3702518.", "ArticleIdList": ["10.1155/2019/3702518"]}, {"Citation": "Pastorin G. Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?. Pharm. Res. 2009, 26 (4), 746\u2013769. 10.1007/s11095-008-9811-0.", "ArticleIdList": ["10.1007/s11095-008-9811-0", "19142717"]}, {"Citation": "Tsai H. C.; Lin J. Y.; Maryani F.; Huang C. C.; Imae T. Drug-loading capacity and nuclear targeting of multiwalled carbon nanotubes grafted with anionic amphiphilic copolymers. Int. J. Nanomed. 2013, 8, 4427\u20134440. 10.2147/IJN.S53636.", "ArticleIdList": ["10.2147/IJN.S53636", "PMC3838018", "24277987"]}, {"Citation": "Chary P. S.; Bhawale R.; Vasave R.; Rajana N.; Singh P. K.; Madan J.; Singh S. B.; Mehra N. K. A review on emerging role of multifunctional carbon nanotubes as an armament in cancer therapy, imaging and biosensing. J. Drug Delivery Sci. Technol. 2023, 85, 104588.10.1016/j.jddst.2023.104588.", "ArticleIdList": ["10.1016/j.jddst.2023.104588"]}, {"Citation": "Ma J.; Wang G.; Ding X.; Wang F.; Zhu C.; Rong Y. Carbon-Based Nanomaterials as Drug Delivery Agents for Colorectal Cancer: Clinical Preface to Colorectal Cancer Citing Their Markers and Existing Theranostic Approaches. ACS Omega 2023, 8 (12), 10656\u201310668. 10.1021/acsomega.2c06242.", "ArticleIdList": ["10.1021/acsomega.2c06242", "PMC10061522", "37008124"]}, {"Citation": "Lacerda L.; Russier J.; Pastorin G.; Herrero M. A.; Venturelli E.; Dumortier H.; Al-Jamal K. T.; Prato M.; Kostarelos K.; Bianco A. Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. Biomaterials 2012, 33 (11), 3334\u20133343. 10.1016/j.biomaterials.2012.01.024.", "ArticleIdList": ["10.1016/j.biomaterials.2012.01.024", "22289266"]}, {"Citation": "Kostarelos K.; Lacerda L.; Pastorin G.; Wu W.; Wieckowski S.; Luangsivilay J.; Godefroy S.; Pantarotto D.; Briand J.-P.; Muller S.; et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2007, 2 (2), 108\u2013113. 10.1038/nnano.2006.209.", "ArticleIdList": ["10.1038/nnano.2006.209", "18654229"]}, {"Citation": "Fujita K.; Obara S.; Maru J.; Endoh S. Cytotoxicity profiles of multi-walled carbon nanotubes with different physico-chemical properties. Toxicol. Mech. Methods 2020, 30 (7), 477\u2013489. 10.1080/15376516.2020.1761920.", "ArticleIdList": ["10.1080/15376516.2020.1761920", "32345130"]}, {"Citation": "Yang Z.; Zhang Y.; Yang Y.; Sun L.; Han D.; Li H.; Wang C. Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease. Nanomedicine 2010, 6 (3), 427\u2013441. 10.1016/j.nano.2009.11.007.", "ArticleIdList": ["10.1016/j.nano.2009.11.007", "20056170"]}, {"Citation": "Ursini C. L.; Maiello R.; Ciervo A.; Fresegna A. M.; Buresti G.; Superti F.; Marchetti M.; Iavicoli S.; Cavallo D. Evaluation of uptake, cytotoxicity and inflammatory effects in respiratory cells exposed to pristine and -OH and -COOH functionalized multi-wall carbon nanotubes. J. Appl. Toxicol. 2016, 36 (3), 394\u2013403. 10.1002/jat.3228.", "ArticleIdList": ["10.1002/jat.3228", "26370214"]}, {"Citation": "Rastogi V.; Yadav P.; Bhattacharya S. S.; Mishra A. K.; Verma N.; Verma A.; Pandit J. K. Carbon nanotubes: an emerging drug carrier for targeting cancer cells. J. Drug Delivery 2014, 2014, 670815.10.1155/2014/670815.", "ArticleIdList": ["10.1155/2014/670815", "PMC4020363", "24872894"]}, {"Citation": "Chashoo G.; Singh S. K.; Qazi N. A.; Saxena A. K. Nanoparticle based drug delivery system: milestone for cancer therapy. J. Biomed. Pharm. Res. 2012, 1 (2), 1\u20136."}, {"Citation": "Leyva-Gonz\u00e1lez C. A.; Salas-Trevi\u00f1o D.; Contreras-Torres F. F.; Loera-Arias M. d. J.; G\u00f3mez-Trist\u00e1n C. A.; Pi\u00f1a-Mendoza E. I.; Garc\u00eda-Rivas G. d. J.; Guill\u00e9n-Mel\u00e9ndez G. A.; Montes-de-Oca-Luna R.; Saucedo-C\u00e1rdenas O.; et al. Hyaluronate Functionalized Multi-Wall Carbon Nanotubes Loaded with Carboplatin Enhance Cytotoxicity on Human Cancer Cell Lines. Materials 2021, 14 (13), 3622.10.3390/ma14133622.", "ArticleIdList": ["10.3390/ma14133622", "PMC8269704", "34209588"]}, {"Citation": "Yoong S. L.; Wong B. S.; Zhou Q. L.; Chin C. F.; Li J.; Venkatesan T.; Ho H. K.; Yu V.; Ang W. H.; Pastorin G. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. Biomaterials 2014, 35 (2), 748\u2013759. 10.1016/j.biomaterials.2013.09.036.", "ArticleIdList": ["10.1016/j.biomaterials.2013.09.036", "24140044"]}, {"Citation": "Srinivasan S.; Koduru S.; Kumar R.; Venguswamy G.; Kyprianou N.; Damodaran C. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int. J. Cancer 2009, 125 (4), 961\u2013967. 10.1002/ijc.24419.", "ArticleIdList": ["10.1002/ijc.24419", "19384950"]}, {"Citation": "Li F.; Fernandez P. P.; Rajendran P.; Hui K. M.; Sethi G. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Lett. 2010, 292 (2), 197\u2013207. 10.1016/j.canlet.2009.12.003.", "ArticleIdList": ["10.1016/j.canlet.2009.12.003", "20053498"]}, {"Citation": "Chen P.-S.; Shih Y.-W.; Huang H.-C.; Cheng H.-W. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PloS One 2011, 6 (5), e2016410.1371/journal.pone.0020164.", "ArticleIdList": ["10.1371/journal.pone.0020164", "PMC3100339", "21629786"]}, {"Citation": "Chen Y.; Tang Y.-M.; Yu S.-L.; Han Y.-W.; Kou J.-P.; Liu B.-L.; Yu B.-Y. Advances in the pharmacological activities and mechanisms of diosgenin. Chin. J. Nat. Med. 2015, 13 (8), 578\u2013587. 10.1016/S1875-5364(15)30053-4.", "ArticleIdList": ["10.1016/S1875-5364(15)30053-4", "26253490"]}, {"Citation": "Yin H.; Zhang M.-J.; An R.-F.; Zhou J.; Liu W.; Morris-Natschke S. L.; Cheng Y.-Y.; Lee K.-H.; Huang X.-F. Diosgenin Derivatives as Potential Antitumor Agents: Synthesis, Cytotoxicity, and Mechanism of Action. J. Nat. Prod. 2021, 84 (3), 616\u2013629. 10.1021/acs.jnatprod.0c00698.", "ArticleIdList": ["10.1021/acs.jnatprod.0c00698", "33381964"]}, {"Citation": "Hajizadeh M. R.; Parvaz N.; Barani M.; Khoshdel A.; Fahmidehkar M. A.; Mahmoodi M.; Torkzadeh-Mahani M. Diosgenin-loaded niosome as an effective phytochemical nanocarrier: physicochemical characterization, loading efficiency, and cytotoxicity assay. Daru 2019, 27 (1), 329\u2013339. 10.1007/s40199-019-00277-0.", "ArticleIdList": ["10.1007/s40199-019-00277-0", "PMC6592984", "31134490"]}, {"Citation": "Li C.; Dai J.; Zheng D.; Zhao J.; Tao Y.; Lei J.; Xi X.; Liu J. An efficient prodrug-based nanoscale delivery platform constructed by water soluble eight-arm-polyethylene glycol-diosgenin conjugate. Mater. Sci. Eng., C 2019, 98, 153\u2013160. 10.1016/j.msec.2018.12.078.", "ArticleIdList": ["10.1016/j.msec.2018.12.078", "30813015"]}, {"Citation": "Sharma N.; Singhal M.; Kumari R. M.; Gupta N.; Manchanda R.; Syed A.; Bahkali A. H.; Nimesh S. Diosgenin Loaded Polymeric Nanoparticles with Potential Anticancer Efficacy. Biomolecules 2020, 10 (12), 1679.10.3390/biom10121679.", "ArticleIdList": ["10.3390/biom10121679", "PMC7765552", "33339083"]}, {"Citation": "Stompor-Gor\u0105cy M.; Machaczka M. Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid. Int. J. Mol. Sci. 2021, 22 (23), 12889.10.3390/ijms222312889.", "ArticleIdList": ["10.3390/ijms222312889", "PMC8657461", "34884693"]}, {"Citation": "Ero\u011flu C.; Se\u00e7me M.; Ba\u011fc\u0131 G.; Dodurga Y. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines. Tumor Biol. 2015, 36 (12), 9437\u20139446. 10.1007/s13277-015-3689-3.", "ArticleIdList": ["10.1007/s13277-015-3689-3", "26124008"]}, {"Citation": "Alazzouni A. S.; Dkhil M. A.; Gadelmawla M. H. A.; Gabri M. S.; Farag A. H.; Hassan B. N. Ferulic acid as anticarcinogenic agent against 1,2-dimethylhydrazine induced colon cancer in rats. J. King Saud Univ., Sci. 2021, 33 (2), 101354.10.1016/j.jksus.2021.101354.", "ArticleIdList": ["10.1016/j.jksus.2021.101354"]}, {"Citation": "Zhang X.; Lin D.; Jiang R.; Li H.; Wan J.; Li H. Ferulic acid exerts antitumor activity and inhibits metastasis in breast cancer cells by regulating epithelial to mesenchymal transition. Oncol. Rep. 2016, 36 (1), 271\u2013278. 10.3892/or.2016.4804.", "ArticleIdList": ["10.3892/or.2016.4804", "27177074"]}, {"Citation": "Senthil Kumar C.; Thangam R.; Mary S. A.; Kannan P. R.; Arun G.; Madhan B. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells. Carbohydr. Polym. 2020, 231, 115682.10.1016/j.carbpol.2019.115682.", "ArticleIdList": ["10.1016/j.carbpol.2019.115682", "31888816"]}, {"Citation": "Helmy S. A.; El-Mofty S.; El Gayar A. M.; El-Sherbiny I. M.; El-Far Y. M. Novel doxorubicin/folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed. Pharmacother. 2022, 145, 112376.10.1016/j.biopha.2021.112376.", "ArticleIdList": ["10.1016/j.biopha.2021.112376", "34749055"]}, {"Citation": "Grasso R.; Dell\u2019Albani P.; Carbone C.; Spatuzza M.; Bonfanti R.; Sposito G.; Puglisi G.; Musumeci F.; Scordino A.; Campisi A. Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies. Sci. Rep. 2020, 10 (1), 4680.10.1038/s41598-020-61670-3.", "ArticleIdList": ["10.1038/s41598-020-61670-3", "PMC7070080", "32170186"]}, {"Citation": "Khan A.; Alamry K. A.. Surface Modified Carbon Nanotubes: An Introduction. In Surface Modified Carbon Nanotubes Vol. 1: Fundamentals, Synthesis and Recent Trends; ACS Symposium Series; American Chemical Society, 2022; Vol. 1424, pp 1\u201325."}, {"Citation": "Gui M. M.; Yap Y. X.; Chai S.-P.; Mohamed A. R. Multi-walled carbon nanotubes modified with (3-aminopropyl)triethoxysilane for effective carbon dioxide adsorption. Int. J. Greenhouse Gas Control 2013, 14, 65\u201373. 10.1016/j.ijggc.2013.01.004.", "ArticleIdList": ["10.1016/j.ijggc.2013.01.004"]}, {"Citation": "Stobinski L.; Lesiak B.; K\u00f6v\u00e9r L.; T\u00f3th J.; Biniak S.; Trykowski G.; Judek J. Multiwall carbon nanotubes purification and oxidation by nitric acid studied by the FTIR and electron spectroscopy methods. J. Alloys Compd. 2010, 501 (1), 77\u201384. 10.1016/j.jallcom.2010.04.032.", "ArticleIdList": ["10.1016/j.jallcom.2010.04.032"]}, {"Citation": "Yoo J.; Park C.; Yi G.; Lee D.; Koo H. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers 2019, 11, 640.10.3390/cancers11050640.", "ArticleIdList": ["10.3390/cancers11050640", "PMC6562917", "31072061"]}, {"Citation": "Herdiana Y.; Wathoni N.; Shamsuddin S.; Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon 2022, 8 (1), e0867410.1016/j.heliyon.2021.e08674.", "ArticleIdList": ["10.1016/j.heliyon.2021.e08674", "PMC8741465", "35028457"]}, {"Citation": "Bradley M. O.; Swindell C. S.; Anthony F. H.; Witman P. A.; Devanesan P.; Webb N. L.; Baker S. D.; Wolff A. C.; Donehower R. C. Tumor targeting by conjugation of DHA to paclitaxel. J. Controlled Release 2001, 74 (1\u20133), 233\u2013236. 10.1016/S0168-3659(01)00321-2.", "ArticleIdList": ["10.1016/S0168-3659(01)00321-2", "11489499"]}, {"Citation": "Khan A. A.; Alanazi A. M.; Jabeen M.; Chauhan A.; Abdelhameed A. S. Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate. Anticancer Res. 2013, 33 (6), 2517\u20132524.", "ArticleIdList": ["23749903"]}, {"Citation": "Mi F.-L.; Wu Y.-Y.; Chiu Y.-L.; Chen M.-C.; Sung H.-W.; Yu S.-H.; Shyu S.-S.; Huang M.-F. Synthesis of a Novel Glycoconjugated Chitosan and Preparation of Its Derived Nanoparticles for Targeting HepG2 Cells. Biomacromolecules 2007, 8 (3), 892\u2013898. 10.1021/bm060998b.", "ArticleIdList": ["10.1021/bm060998b", "17316043"]}, {"Citation": "AbouAitah K.; Hassan H. A.; Swiderska-Sroda A.; Gohar L.; Shaker O. G.; Wojnarowicz J.; Opalinska A.; Smalc-Koziorowska J.; Gierlotka S.; Lojkowski W. Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles. Cancers 2020, 12 (1), 144.10.3390/cancers12010144.", "ArticleIdList": ["10.3390/cancers12010144", "PMC7017376", "31936103"]}, {"Citation": "AbouAitah K.; Stefanek A.; Higazy I. M.; Janczewska M.; Swiderska-Sroda A.; Chodara A.; Wojnarowicz J.; Sza\u0142aj U.; Shahein S. A.; Aboul-Enein A. M.; et al. Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles. Pharmaceutics 2020, 12 (1), 70.10.3390/pharmaceutics12010070.", "ArticleIdList": ["10.3390/pharmaceutics12010070", "PMC7022489", "31963155"]}, {"Citation": "Shahein S. A.; Aboul-Enein A. M.; Higazy I. M.; Abou-Elella F.; Lojkowski W.; Ahmed E. R.; Mousa S. A.; AbouAitah K. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Int. J. Nanomed. 2019, 14, 5503\u20135526. 10.2147/IJN.S206899.", "ArticleIdList": ["10.2147/IJN.S206899", "PMC6650459", "31410001"]}, {"Citation": "AbouAitah K.; Higazy I. M.; Swiderska-Sroda A.; Abdelhameed R. M.; Gierlotka S.; Mohamed T. A.; Sza\u0142aj U.; Lojkowski W. Anti-inflammatory and antioxidant effects of nanoformulations composed of metal-organic frameworks delivering rutin and/or piperine natural agents. Drug Delivery 2021, 28 (1), 1478\u20131495. 10.1080/10717544.2021.1949073.", "ArticleIdList": ["10.1080/10717544.2021.1949073", "PMC8280904", "34254539"]}, {"Citation": "Li R.; Bao Z.; Wang P.; Deng Y.; Fan J.; Zhu X.; Xia X.; Song Y.; Yao H.; Li D. Gelatin-Functionalized Carbon Nanotubes Loaded with Cisplatin for Anti-Cancer Therapy. Polymers 2023, 15, 3333.10.3390/polym15163333.", "ArticleIdList": ["10.3390/polym15163333", "PMC10458187", "37631391"]}, {"Citation": "Pei X.; Zhu Z.; Gan Z.; Chen J.; Zhang X.; Cheng X.; Wan Q.; Wang J. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity. Sci. Rep. 2020, 10 (1), 2717.10.1038/s41598-020-59624-w.", "ArticleIdList": ["10.1038/s41598-020-59624-w", "PMC7026168", "32066812"]}, {"Citation": "Chen X.-H.; Chen C.-S.; Xiao H.-N.; Chen X.-H.; Li W.-H.; Xu L.-S. Lipophilic functionalization of multi-walled carbon nanotubes with stearic acid. Carbon 2005, 43 (8), 1800\u20131803. 10.1016/j.carbon.2005.02.008.", "ArticleIdList": ["10.1016/j.carbon.2005.02.008"]}, {"Citation": "Sharma S.; Mehra N. K.; Jain K.; Jain N. K. Effect of functionalization on drug delivery potential of carbon nanotubes. Artif. Cells, Nanomed., Biotechnol. 2016, 44 (8), 1851\u20131860. 10.3109/21691401.2015.1111227.", "ArticleIdList": ["10.3109/21691401.2015.1111227", "26732473"]}, {"Citation": "Karimi A.; Erfan M.; Mortazavi S. A.; Ghorbani-Bidkorbeh F.; Landi B.; Kobarfard F.; Shirazi F. H. The Photothermal Effect of Targeted Methotrexate-Functionalized Multi-Walled Carbon Nanotubes on MCF7 Cells. Iran. J. Pharm. Res. 2019, 18 (Suppl1), 221\u2013236. 10.22037/ijpr.2020.14484.12423.", "ArticleIdList": ["10.22037/ijpr.2020.14484.12423", "PMC7393047", "32802102"]}, {"Citation": "Karnati K. R.; Wang Y. Understanding the co-loading and releasing of doxorubicin and paclitaxel using chitosan functionalized single-walled carbon nanotubes by molecular dynamics simulations. Phys. Chem. Chem. Phys. 2018, 20 (14), 9389\u20139400. 10.1039/C8CP00124C.", "ArticleIdList": ["10.1039/C8CP00124C", "PMC5898243", "29565091"]}, {"Citation": "Wolski P.; Nieszporek K.; Panczyk T. Pegylated and folic acid functionalized carbon nanotubes as pH controlled carriers of doxorubicin. Molecular dynamics analysis of the stability and drug release mechanism. Phys. Chem. Chem. Phys. 2017, 19 (13), 9300\u20139312. 10.1039/C7CP00702G.", "ArticleIdList": ["10.1039/C7CP00702G", "28323298"]}, {"Citation": "Liu Z.; Sun X.; Nakayama-Ratchford N.; Dai H. Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery. ACS Nano 2007, 1 (1), 50\u201356. 10.1021/nn700040t.", "ArticleIdList": ["10.1021/nn700040t", "19203129"]}, {"Citation": "Azqhandi M. H. A.; Farahani B. V.; Dehghani N. Encapsulation of methotrexate and cyclophosphamide in interpolymer complexes formed between poly acrylic acid and poly ethylene glycol on multi-walled carbon nanotubes as drug delivery systems. Mater. Sci. Eng., C 2017, 79, 841\u2013847. 10.1016/j.msec.2017.05.089.", "ArticleIdList": ["10.1016/j.msec.2017.05.089", "28629088"]}, {"Citation": "Chudoba D.; Ja\u017cd\u017cewska M.; \u0141udzik K.; Wo\u0142oszczuk S.; Juszy\u0144ska-Ga\u0142\u0105zka E.; Ko\u015bci\u0144ski M. Description of Release Process of Doxorubicin from Modified Carbon Nanotubes. Int. J. Mol. Sci. 2021, 22 (21), 12003.10.3390/ijms222112003.", "ArticleIdList": ["10.3390/ijms222112003", "PMC8584310", "34769431"]}, {"Citation": "Tan J. M.; Karthivashan G.; Arulselvan P.; Fakurazi S.; Hussein M. Z. Characterization and In Vitro Sustained Release of Silibinin from pH Responsive Carbon Nanotube-Based Drug Delivery System. J. Nanomater. 2014, 2014, 439873.10.1155/2014/439873.", "ArticleIdList": ["10.1155/2014/439873"]}, {"Citation": "Yao H.; Zhu M.; Wang P.; Liu Y.; Wei J. Combination of Mussel Inspired Method and \u201cThiol-Michael\u201d Click Reaction for Biocompatible Alginate-Modified Carbon Nanotubes. Nanomaterials 2021, 11 (9), 2191.10.3390/nano11092191.", "ArticleIdList": ["10.3390/nano11092191", "PMC8471357", "34578507"]}, {"Citation": "Smart S. K.; Cassady A. I.; Lu G. Q.; Martin D. J. The biocompatibility of carbon nanotubes. Carbon 2006, 44 (6), 1034\u20131047. 10.1016/j.carbon.2005.10.011.", "ArticleIdList": ["10.1016/j.carbon.2005.10.011"]}, {"Citation": "Yan Y.; Wang R.; Hu Y.; Sun R.; Song T.; Shi X.; Yin S. Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors. Drug Delivery 2018, 25 (1), 1607\u20131616. 10.1080/10717544.2018.1501120.", "ArticleIdList": ["10.1080/10717544.2018.1501120", "PMC6201812", "30348025"]}, {"Citation": "Wu L.; Man C.; Wang H.; Lu X.; Ma Q.; Cai Y.; Ma W. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin. Pharm. Res. 2013, 30 (2), 412\u2013423. 10.1007/s11095-012-0883-5.", "ArticleIdList": ["10.1007/s11095-012-0883-5", "22992831"]}, {"Citation": "Richert M.; Trykowski G.; Walczyk M.; Cie\u015blak M. J.; Ka\u017amierczak-Bara\u0144ska J.; Kr\u00f3lewska-Goli\u0144ska K.; Sobczak J. W.; Biniak S. Modification of multiwalled carbon nanotubes with a ruthenium drug candidate\u2014indazolium[tetrachlorobis(1H-indazole)ruthenate(iii)] (KP1019). Dalton Trans. 2020, 49 (46), 16791\u201316800. 10.1039/D0DT03528A.", "ArticleIdList": ["10.1039/D0DT03528A", "33174575"]}, {"Citation": "Jiang X.; Ma M.; Li M.; Shao S.; Yuan H.; Hu F.; Liu J.; Huang X. Preparation and Evaluation of Novel Emodin-loaded Stearic Acid-g-chitosan Oligosaccharide Nanomicelles. Nanoscale Res. Lett. 2020, 15 (1), 93.10.1186/s11671-020-03304-1.", "ArticleIdList": ["10.1186/s11671-020-03304-1", "PMC7183521", "32335740"]}, {"Citation": "Kopp F.; Mendell J. T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 2018, 172 (3), 393\u2013407. 10.1016/j.cell.2018.01.011.", "ArticleIdList": ["10.1016/j.cell.2018.01.011", "PMC5978744", "29373828"]}, {"Citation": "Heo M. J.; Yun J.; Kim S. G. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Arch. Pharmacal Res. 2019, 42 (1), 48\u201362. 10.1007/s12272-018-01104-x.", "ArticleIdList": ["10.1007/s12272-018-01104-x", "30610616"]}, {"Citation": "Tsai W. C.; Hsu S. D.; Hsu C. S.; Lai T. C.; Chen S. J.; Shen R.; Huang Y.; Chen H. C.; Lee C. H.; Tsai T. F.; et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 2012, 122 (8), 2884\u20132897. 10.1172/JCI63455.", "ArticleIdList": ["10.1172/JCI63455", "PMC3408747", "22820290"]}, {"Citation": "Shaker O. G.; Senousy M. A.; Elbaz E. M. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients. Sci. Rep. 2017, 7 (1), 16246.10.1038/s41598-017-16500-4.", "ArticleIdList": ["10.1038/s41598-017-16500-4", "PMC5701156", "29176650"]}, {"Citation": "Mehra M.; Chauhan R. Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma. Biomarkers Cancer 2017, 9, 1179299X1773730.10.1177/1179299x17737301.", "ArticleIdList": ["10.1177/1179299x17737301", "PMC5673005", "29147078"]}, {"Citation": "Panzitt K.; Tschernatsch M. M.; Guelly C.; Moustafa T.; Stradner M.; Strohmaier H. M.; Buck C. R.; Denk H.; Schroeder R.; Trauner M.; et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007, 132 (1), 330\u2013342. 10.1053/j.gastro.2006.08.026.", "ArticleIdList": ["10.1053/j.gastro.2006.08.026", "17241883"]}, {"Citation": "Matouk I. J.; DeGroot N.; Mezan S.; Ayesh S.; Abu-lail R.; Hochberg A.; Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007, 2 (9), e84510.1371/journal.pone.0000845.", "ArticleIdList": ["10.1371/journal.pone.0000845", "PMC1959184", "17786216"]}, {"Citation": "Geng Y. J.; Xie S. L.; Li Q.; Ma J.; Wang G. Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 2011, 39 (6), 2119\u20132128. 10.1177/147323001103900608.", "ArticleIdList": ["10.1177/147323001103900608", "22289527"]}, {"Citation": "Cheng D.; Deng J.; Zhang B.; He X.; Meng Z.; Li G.; Ye H.; Zheng S.; Wei L.; Deng X.; et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine 2018, 36, 159\u2013170. 10.1016/j.ebiom.2018.08.055.", "ArticleIdList": ["10.1016/j.ebiom.2018.08.055", "PMC6197532", "30195653"]}, {"Citation": "Tsang F. H.; Au S. L.; Wei L.; Fan D. N.; Lee J. M.; Wong C. C.; Ng I. O.; Wong C. M. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver Int. 2015, 35 (5), 1597\u20131606. 10.1111/liv.12746.", "ArticleIdList": ["10.1111/liv.12746", "25424744"]}, {"Citation": "Yang Z.; Lu Y.; Xu Q.; Tang B.; Park C. K.; Chen X. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Dis. Markers 2015, 2015, 191029.10.1155/2015/191029.", "ArticleIdList": ["10.1155/2015/191029", "PMC4475561", "26136615"]}, {"Citation": "Deng L.; Yang S. B.; Xu F. F.; Zhang J. H. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J. Exp. Clin. Cancer Res. 2015, 34 (1), 18.10.1186/s13046-015-0136-7.", "ArticleIdList": ["10.1186/s13046-015-0136-7", "PMC4339002", "25884472"]}, {"Citation": "Cantile M.; Di Bonito M.; Tracey De Bellis M.; Botti G. Functional Interaction among lncRNA HOTAIR and MicroRNAs in Cancer and Other Human Diseases. Cancers 2021, 13 (3), 570.10.3390/cancers13030570.", "ArticleIdList": ["10.3390/cancers13030570", "PMC7867281", "33540611"]}, {"Citation": "Paraskevopoulou M. D.; Vlachos I. S.; Karagkouni D.; Georgakilas G.; Kanellos I.; Vergoulis T.; Zagganas K.; Tsanakas P.; Floros E.; Dalamagas T.; et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016, 44 (D1), D231\u2013D238. 10.1093/nar/gkv1270.", "ArticleIdList": ["10.1093/nar/gkv1270", "PMC4702897", "26612864"]}, {"Citation": "Liang Y.; Liang Q.; Qiao L.; Xiao F. MicroRNAs Modulate Drug Resistance-Related Mechanisms in Hepatocellular Carcinoma. Front. Oncol. 2020, 10, 920.10.3389/fonc.2020.00920.", "ArticleIdList": ["10.3389/fonc.2020.00920", "PMC7338562", "32695666"]}, {"Citation": "Ding W.; Tan H.; Zhao C.; Li X.; Li Z.; Jiang C.; Zhang Y.; Wang L. MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumor Biol. 2016, 37 (5), 6255\u20136260. 10.1007/s13277-015-4462-3.", "ArticleIdList": ["10.1007/s13277-015-4462-3", "26615424"]}, {"Citation": "Zhang T.; Yang Z.; Kusumanchi P.; Han S.; Liangpunsakul S. Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases. Front Med. 2020, 7, 7.10.3389/fmed.2020.00007.", "ArticleIdList": ["10.3389/fmed.2020.00007", "PMC7005070", "32083086"]}, {"Citation": "Zhao B.; Zhu Y.; Cui K.; Gao J.; Yu F.; Chen L.; Li S. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma. Mol. Med. Rep. 2013, 7 (5), 1413\u20131416. 10.3892/mmr.2013.1406.", "ArticleIdList": ["10.3892/mmr.2013.1406", "23546593"]}, {"Citation": "Zhang J.; Jiao J.; Cermelli S.; Muir K.; Jung K. H.; Zou R.; Rashid A.; Gagea M.; Zabludoff S.; Kalluri R.; et al. miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. Cancer Res. 2015, 75 (9), 1859\u20131867. 10.1158/0008-5472.CAN-14-1254.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-1254", "PMC4603420", "25769721"]}, {"Citation": "Tao J.; Jiang L.; Chen X. Roles of microRNA in liver cancer. Liver Res. 2018, 2 (2), 61\u201372. 10.1016/j.livres.2018.06.002.", "ArticleIdList": ["10.1016/j.livres.2018.06.002"]}, {"Citation": "Gao P.; Wong C. C.; Tung E. K.; Lee J. M.; Wong C. M.; Ng I. O. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J. Hepatol. 2011, 54 (6), 1177\u20131184. 10.1016/j.jhep.2010.09.023.", "ArticleIdList": ["10.1016/j.jhep.2010.09.023", "21145831"]}, {"Citation": "Zhang K.; Zhang M.; Luo Z.; Wen Z.; Yan X. The dichotomous role of TGF-\u03b2 in controlling liver cancer cell survival and proliferation. J. Genet. Genomics 2020, 47 (9), 497\u2013512. 10.1016/j.jgg.2020.09.005.", "ArticleIdList": ["10.1016/j.jgg.2020.09.005", "33339765"]}, {"Citation": "Yu Y.; Feng X. H. TGF-\u03b2 signaling in cell fate control and cancer. Curr. Opin. Cell Biol. 2019, 61, 56\u201363. 10.1016/j.ceb.2019.07.007.", "ArticleIdList": ["10.1016/j.ceb.2019.07.007", "31382143"]}, {"Citation": "Dituri F.; Mancarella S.; Cigliano A.; Chieti A.; Giannelli G. TGF-\u03b2 as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives. Semin. Liver Dis. 2019, 39 (01), 053\u2013069. 10.1055/s-0038-1676121.", "ArticleIdList": ["10.1055/s-0038-1676121", "30586675"]}, {"Citation": "Katz L. H.; Likhter M.; Jogunoori W.; Belkin M.; Ohshiro K.; Mishra L. TGF-\u03b2 signaling in liver and gastrointestinal cancers. Cancer Lett. 2016, 379 (2), 166\u2013172. 10.1016/j.canlet.2016.03.033.", "ArticleIdList": ["10.1016/j.canlet.2016.03.033", "PMC5107316", "27039259"]}, {"Citation": "Breier G.; Grosser M.; Rezaei M. Endothelial cadherins in cancer. Cell Tissue Res. 2014, 355 (3), 523\u2013527. 10.1007/s00441-014-1851-7.", "ArticleIdList": ["10.1007/s00441-014-1851-7", "24619142"]}, {"Citation": "Song Y.; Ye M.; Zhou J.; Wang Z.; Zhu X. Targeting E-cadherin expression with small molecules for digestive cancer treatment. Am. J. Transl. Res. 2019, 11 (7), 3932\u20133944.", "ArticleIdList": ["PMC6684918", "31396310"]}, {"Citation": "Chen J.; Zhao J.; Ma R.; Lin H.; Liang X.; Cai X. Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis. PloS One 2014, 9 (8), e10395210.1371/journal.pone.0103952.", "ArticleIdList": ["10.1371/journal.pone.0103952", "PMC4122395", "25093414"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "20", "Hour": "11", "Minute": "51"}, {"Year": "2024", "Month": "1", "Day": "23", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "22", "Hour": "18", "Minute": "24"}, {"Year": "2024", "Month": "2", "Day": "21"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38253026", "PMC10880110", "10.1021/acsabm.3c00700"]}}]}